Royal Philips has entered an agreement with the Singapore Institute of Advanced Medicine Holdings (SAM) to build a new oncology centre in the country.

To be built in collaboration with Varian Medical Systems and IBA Worldwide, and based at the country’s biomedical research hub Biopolis, the new Advanced Medicine Oncology Centre will offer imaging, treatment delivery and clinical informatics technologies.

SAM is set to invest approximately S$100m ($72m) for the development of the research, training and treatment centre that is scheduled to open in stages from next year.

In addition to oncology solutions for healthcare professionals and researchers, the centre is expected to provide a professional training platform.

The centre will also act as a site for research, clinical trials and cancer therapies development, delivering treatment protocols for personalised patient care, better outcomes and improved quality of life.

Singapore Institute of Advanced Medicine Holdings founder and chairman Dr Djeng Shih Kien said: “The new Advanced Medicine Oncology Centre aligns with the founding goal of the Singapore Institute of Advanced Medicine Holdings to provide earlier detection and first-time-right diagnosis of cancer as well as safer, more cost-effective treatment by advancing care enabled through research, technology and education.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
"The centre will also act as a site for research, clinical trials and cancer therapies development, delivering treatment protocols for personalised patient care, better outcomes and improved quality of life."

Philips’ diagnostic imaging systems and clinical informatics such as Ingenia MR, IQon spectral CT systems and Vereos PET/CT scanners will be available at the new centre. Varian’s ProBeam Compact system and IBA’s Cyclone Kiube technology will also be accessible.

Philips ASEAN Pacific Health Systems general manager Diederik Zeven said: “Philips is enabling the advancement of medical research through our deep heritage in healthcare innovation and collaboration with medical partners.

“The new Advanced Medicine Oncology Centre is well-positioned to spearhead cancer research and treatment in Singapore and the region."

The oncology centre will also use Philips IntelliSpace Portal 9.0 to enable advanced visual analysis and quantification of medical images resulting in fast assessment and diagnosis.


Image: Philips Vereos PET/CT scanner is the world’s first and only fully digital PET/CT system. Photo: courtesy of Koninklijke Philips NV.